Stock Screener App

Frei -

Installieren

1.41

2.08% -0.03

after-market

Handel nachbörslich: 1.41

In 8 Bio Inc (INAB)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der In 8 Bio Inc-Aktie (INAB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.61% 0.113	0.107	0.11	0.064	0.023
Operating Expenses	23.73% 3.967	5.201	5.66	6.224	7.109
Benefits Costs and Expenses	23.73% 3.967	5.201	5.66	11.78	7.109
Costs And Expenses	23.73% 3.967	5.201	5.66	6.224	7.109
Operating Income/Loss	24.34% -3.854	-5.094	-5.55	-6.16	-7.086
Income/Loss From Continuing Operations Before Tax	24.34% -3.854	-5.094	-5.55	-11.71	-7.086
Income/Loss From Continuing Operations After Tax	24.34% -3.854	-5.094	-5.55	-6.16	-7.086
Net Income/Loss	24.34% -3.854	-5.094	-5.55	-6.16	-7.086
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	10.16% 4.5377	4.1192	83.48	7.8564	47.32
Diluted Average Shares	10.16% 4.5377	4.1192	83.48	7.8564	47.32
Basic Earnings Per Share	31.45% -0.85	-1.24	-0.07	-0.04	-0.15
Diluted Earnings Per Share	31.45% -0.85	-1.24	-0.07	-0.04	-0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$48.77

0.87%

ROIV

$27.88

1.59%

RPRX

$47.32

2.57%

BNTX

$91.28

0.11%

ONC

$302.49

2.67%

INSM

$163.81

0.85%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters